Evidence map›Paper›PMID 36365337›Full record

ArticlePlants (Basel, Switzerland)2022

Bioassay Guided Fractionation Protocol for Determining Novel Active Compounds in Selected Australian Flora.

Janice Mani, Joel Johnson, Holly Hosking, Beatriz E Hoyos, Kerry B Walsh, Paul Neilsen, Mani Naiker

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Bioactive compound identification without fractionation: an Ocimum spp. case study.Metabolomics : Official journal of the Metabolomic Society · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Plant Metabolomics: The Future of Anticancer Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  16. Bioassay-Guided Fractionation ofPlants (Basel, Switzerland) · 2024
    Article
  17. Review
  18. Antibacterial Potency of an Active Compound fromMolecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Janice ManiSchool of Health, Medical and Applied Sciences, Central Queensland University, Bruce Hwy, North Rockhampton, QLD 4701, Australia.ORCID 0000-0003-0195-0465
Joel JohnsonSchool of Health, Medical and Applied Sciences, Central Queensland University, Bruce Hwy, North Rockhampton, QLD 4701, Australia.ORCID 0000-0002-9172-8587
Holly HoskingSchool of Health, Medical and Applied Sciences, Central Queensland University, Bruce Hwy, North Rockhampton, QLD 4701, Australia.ORCID 0000-0002-6998-4082
Beatriz E HoyosSchool of Health, Medical and Applied Sciences, Central Queensland University, Bruce Hwy, North Rockhampton, QLD 4701, Australia.ORCID 0000-0001-8434-8431
Kerry B WalshSchool of Health, Medical and Applied Sciences, Central Queensland University, Bruce Hwy, North Rockhampton, QLD 4701, Australia.ORCID 0000-0002-3033-8622
Paul NeilsenSchool of Health, Medical and Applied Sciences, Central Queensland University, Bruce Hwy, North Rockhampton, QLD 4701, Australia.
Mani NaikerSchool of Health, Medical and Applied Sciences, Central Queensland University, Bruce Hwy, North Rockhampton, QLD 4701, Australia.
Central Queensland University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A large variety of unique and distinct flora of Australia have developed exceptional survival methods and phytochemicals and hence may provide a significant avenue for new drug discovery. This study proposes a bioassay guided fractionation protocol that maybe robust and efficient in screening plants with potential bioactive properties and isolating lead novel compounds. Hence, five native Australian plants were selected for this screening process, namely Pittosporum angustifolium (Gumbi gumbi), Terminalia ferdinandiana (Kakadu plum, seeds (KPS), and flesh (KPF)), Cupaniopsis anacardioides (Tuckeroo, seeds (TKS) and flesh (TKF)), Podocarpus elatus (Illawarra plum, seeds (IPS) and flesh (IPF)) and Pleiogynium timoriense (Burdekin plum, seeds (BPS) and flesh (BPF)). The methanolic extracts of the plants samples were analysed for Total phenolic content (TPC) and antioxidant capacity measure by FRAP. The highest values were found in the KPF which were 20,847 ± 2322 mg GAE/100 g TPC and 100,494 ± 9487 mg TXE/100 g antioxidant capacity. Extracts of GGL was deemed to be most potent with complete cell inhibition in HeLa and HT29, and about 95% inhibition in HuH7 cells. Comparative activity was also seen for KPS extract, where more than 80% cell inhibition occurred in all tested cell lines. Dose-dependent studies showed higher SI values (0.72–1.02) in KPS extracts than GGL (0.5–0.73). Microbial assays of the crude extracts were also performed against five bacterial strains commonly associated with causing food poisoning diseases were selected (Gram positive—Staphylococcus aureus and Gram negative—Escherichia coli, Salmonella typhi and Pseudomonas aeruginosa bacteria). KPF extracts were effective in suppressing microbial growth of all tested bacterial strains except for P. aeruginosa, while TKS and TKF were only slightly effective against S. aureus. Due to the potential of the GGL crude extract to completely inhibit the cells compared to KPS, it was further fractionated and tested against the cell lines. HPLC phenolic profiling of the crude extracts were performed, and numerous peak overlaps were evident in the fruit extracts. The KPF extracts demonstrated the strongest peaks which was coherent with the fact that it had the highest TPC and antioxidant capacity values. A high occurrence of t-ferulic acid in the GGL extracts was found which may explain the cytotoxic activity of GGL extracts. Peaks in KPS and KPF extracts were tentatively identified as gallic acid, protocatechuic acid, 4-hydroxybenzoic acid and syringic acid and possibly ellagic acid. HPLC time-based fractionation of the GGL extract (F1–F5) was performed and Dose dependent cytotoxic effects were determined. It was construed that F1, having the highest SI value for HeLa, HT29 and HuH7 (1.60, 1.41 and 1.67, respectively) would be promising for further fractionation and isolation process.

Indexed as

anticancer activityantioxidant capacitybioassay guided fractionationtotal phenolic content

Identifiers

PMID36365337
PMCPMC9654191
OpenAlexW4307940464

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.